Syra Health Corp. secured a contract with the Mississippi State Department of Health to deliver epidemiology, evaluation, and biostatistics services from September 2026 to September 2029, valued up to $240,000. The contract supports public health decision-making through data analysis, health assessments, GIS mapping, and reporting. This partnership highlights Syra Health's growing role in public health analytics and may extend up to five years with renewals. The company aims to enhance healthcare outcomes by providing actionable insights and affordable, accessible solutions.
Syra Health's new contract with the Mississippi State Department of Health is valued up to $240,000 over three years. For readers following the health sector, here is Pluang's market snapshot as of Sep 29, 2026 19:14 WIB: out of 100 priced US health stocks, 50 rose and 41 fell. Notable movers include ADPT at USD 29.06 with a 1-day change of +1.93% and 100% buy order activity, CYTK at USD 67.24 up 1.63%, and PHG at USD 24.74 down 1.47%.
Micron Technology has signed 16 strategic customer agreements worth at least $100 billion, locking in demand for AI memory through 2030 and ending its historical boom-and-bust cycle. These take-or-pay contracts, backed by $22 billion in deposits, ens...
In September 2026, leading U.S. cannabis companies Cresco Labs, Trulieve Cannabis, and Green Thumb Industries demonstrated significant growth and strategic expansion. Cresco Labs strengthened its position in Pennsylvania with a $50 million acquisitio...
AT&T offers a 4.4% dividend yield with a steady payout, but its free cash flow after capital expenditures and share buybacks barely covers the dividend and repurchases, leaving little margin for error. The company’s debt is rising due to large acquis...
Microsoft's stock closed at $516.17 with a 12-month price target of $628.87, indicating a potential 21.83% upside. Key growth drivers include Azure's revenue growth exceeding 40%, over 30 million paid seats for Microsoft 365 Copilot, and a commercial...
First Solar's stock has fallen about 35% since June, underperforming due to broad solar sector pressures and recent political developments. The decline reflects systemic issues affecting the entire solar industry, as seen with similar drops in Enphas...
